Navigation Links
Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium
Date:12/9/2010

steroids prior to each Taxotere® administration to reduce the incidence and severity of fluid retention. Patients with pre-existing effusions should be closely monitored from the first dose for possible exacerbation of the effusions
  • Treatment-related acute myeloid leukemia (AML) or myelodysplasia has occurred in patients given anthracyclines and/or cyclophosphamide, including use with Taxotere® in adjuvant therapy of breast cancer

  • Localized erythema of the extremities with edema followed by desquamation has been observed

  • In case of severe skin toxicity, an adjustment in dosage is recommended

  • Severe neurosensory symptoms (e.g. paresthesia, dysesthesia, pain) were observed in 5.5% (53/965) of metastatic breast cancer patients, and resulted in treatment discontinuation in 6.1%

  • When these symptoms occur, dosage must be adjusted; if symptoms persist, treatment should be discontinued

  • Severe asthenia was reported in 14.9% (144/965) of metastatic breast cancer patients, but led to treatment discontinuation in only 1.8%

  • Symptoms of fatigue and weakness may last a few days up to several weeks and may be associated with deterioration of performance status in patients with progressive disease

  • Taxotere® (docetaxel) Injection Concentrate can cause fetal harm when administered to pregnant women.  Women of childbearing potential should be advised to avoid becoming pregnant during therapy with Taxotere

  • The most common adverse reactions across all Taxotere indications are infections, neutropenia, anemia, febrile neutropenia, hypersensitivity, thrombocytopenia, neuropathy, dysgeusia, dyspnea, constipation, anorexia, nail disorders, fluid retention, asthenia, pain, nausea, diarrhea, vomiting, mucositis, alopecia, skin reactions and myalgia

  • In patients treated with TCF for gastric cancer, the incidence of serious ad
    '/>"/>

  • SOURCE sanofi-aventis
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
    2. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
    3. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
    4. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
    5. Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
    6. Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance
    7. European Hospital Anticoagulant Market Dominated by Sanofi-Aventiss Clexane
    8. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    9. Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
    10. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
    11. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... , September 1, 2015 ... on the basis of sectors, products & services ... globally coupled with the increasing demand of advanced ... expected to propel the growth for bioinformatics market. ... information efficiently is known as bioinformatics. Decreasing cost ...
    (Date:9/1/2015)... 31, 2015 Research and Markets ( http://www.researchandmarkets.com/research/r8v22b/regulatory ... Affairs for Support Staff (London, UK - September 24-25, ... This two day course provides an introduction to Pharmaceutical ... has been designed specifically for those working in a ... an overview of EU regulatory procedures required to register ...
    (Date:9/1/2015)... -- - The ... data presented at ESC Congress 2015 ... the evolution of manag ing AF in everyday clinical ...   The first-ever two-year outcomes from the Global Anticoagulant Registry in ... all-cause death was the most frequent major event in more than 17,000 newly ...
    Breaking Medicine Technology:Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9
    ... Mich. , June 21 Action Fabricators ... the launch of Laminin Medical Products ( www.LamininMedical.com ), ... of medical products under contract with the Medical Device ... Development Corporation (MEDC) grant through their Economic Development Job ...
    ... can encourage medical device development , ... SILVER SPRING, Md. , June ... to implantable defibrillators help prevent, diagnose, treat, and monitor serious and ... a regulatory review process before entering the marketplace. It then takes ...
    Cached Medicine Technology:Action Fabricators Expands its Footprint in the Healthcare Industry With the Launch of Laminin Medical Products 2FDA to Hold Daylong Meeting on Medical Device Innovation 2FDA to Hold Daylong Meeting on Medical Device Innovation 3
    (Date:9/1/2015)... ... ... September is National Prostate Cancer Awareness Month and Florida Hospital Zephyrhills wants ... in the United States. , Prostate cancer is to men what breast cancer is ... 7 men. One new case occurs every 2.3 minutes and a man dies from ...
    (Date:9/1/2015)... (PRWEB) , ... September 02, 2015 , ... The ... and quality of life, in the USA ”. , As corresponding author Mr Christopher ... the United States. In our study, we endeavoured to better understand how migraine headaches ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... company, is pleased to announce their partnership with Apex Physical Therapy ... groups to continue to provide kind, compassionate, and empathetic care to local residents ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Celebrity hairstylist and Beauty Gives Back ... Beauty Behind the Fashion” on Thursday, Oct. 1, at the La Valencia Hotel. The ... on the collaboration between fashion and professional hair, makeup and nail design. , ...
    (Date:9/1/2015)... ... , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) has once ... Style 50 Report that recognizes companies that provide the best career opportunities for Hispanic ... from number 24 to 21 of the 50 Best Companies for Latinas. The LATINA ...
    Breaking Medicine News(10 mins):Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3
    ... seemed to suggest that supplementing the diet with vitamin ... a study published In Journal Of American Medical association, ... be something very different. ,The researchers had ... Evaluation or HOPE centers between 1993 and 1999, and ...
    ... the fishes contains a property that may cure inflammatory conditions ... in a diet supplemented by low doses of aspirin is ... case of absence of fish, a supplement of fish oil ... shown previously that omega-3 fatty acids in conjunction with daily ...
    ... that lowering LDL cholesterol (“bad” cholesterol) to below ... a // cholesterol-lowering drug is safe and results in ... disease patients. They initially took 10 milligrams of atorvastatin ... to 130 milligrams per deciliter a day or lower. ...
    ... have been conducted to see whether antihypertensive strategies ... // are superior to older treatments with beta-blockers ... calcium channel blocker amlodipine with or without the ... or without the diuretic bendroflumethiazide. ,The trial ...
    ... stem cell research that will help in numerous therapies using ... growing human embryonic stem cells in the laboratory. ... important role in regeneration of cells for therapeutic use. However, ... live animal cells and serum and run the risk of ...
    ... issue of Journal of American Medical Association, researchers have pointed ... delaying the vaccination schedules of the children resulting in increase ... ,According to the latest study, most of the vaccines ... of age in children often gets delayed due to a ...
    Cached Medicine News:
    ... Needles are preominantly used for routine blood ... colour of the needle protective cap simplifies ... For example, yellow symbolises the needle dimension ... (0.80 mm) and black 22 G (0.70 ...
    DiaMed-ID Micro Typing System...
    Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
    ... cell runs up to 12 mini gels ... Handcast gels can be poured 12 at ... gradient former and Mini-PROTEAN 3 multi-casting chamber, ... Alternatively, Ready Gel precast gels offer the ...
    Medicine Products: